Tanner Insights – Access Programs
Medicine should have no borders.
From sponsor to patient, we bridge the gap in providing access to life-saving medicines. Our full-circle approach and innovative delivery model allows us to provide strategic solutions that enables real-world data collection, strengthens the pharmaceutical supply chain and offers physicians and patients the best access experience.
Whitepaper
Why should I read this whitepaper?
- Description of early access programs
- Benefits for patients and sponsors
- Early access programs vs. clinical trials
- How Tanner Pharma Group can help
Download Insights
Leave your details below, and receive the requested content directly in your inbox.
For more information see our Privacy Policy.
Our Experience
20
20 years of supporting patient access
130
Distribution experience in 130+ countries
68
Local resources across 68 countries
1,000 10,000 100,000 1,000,000
Patient lives impacted
OUR PROGRAMS
A range of access solutions to meet your challenges.
-
Licensing, Acquisitions and Commercialization: Commercializing licensed or acquired products via registration & promotion with a focus on Latin America.
-
Managed Access Programs: Enabling biopharmaceutical companies to run programs to supply patients in markets where a medicine does not have a marketing authorization or is not commercially accessible.
-
Clinical Trials Solutions: Sourcing, supply and logistics for biopharmaceutical companies requiring comparator, bioanalytical and biologic products for clinical trials.
-
Global Access Programs: Supporting physicians, hospitals and ministries of health across the globe by providing access to medicine via Named Patient Supply.
